HIGH-DOSE ORAL METOCLOPRAMIDE - AN EFFECTIVE ANTIEMETIC AGENT

被引:7
|
作者
ALAVI, JB
TORRI, S
GLOVER, D
HURWITZ, S
GLICK, JH
机构
[1] UNIV PENN, SCH MED, DEPT MED, HEMATOL ONCOL SECT, PHILADELPHIA, PA 19104 USA
[2] UNIV PENN, SCH MED, CTR CANC, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1097/00000421-198506000-00012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:260 / 265
页数:6
相关论文
共 50 条
  • [1] DOSE-RANGING ANTIEMETIC TRIAL OF HIGH-DOSE ORAL METOCLOPRAMIDE
    TYSON, LB
    GRALLA, RJ
    KRIS, MG
    YOUNG, CW
    CLARK, RA
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (03): : 239 - 243
  • [2] ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE
    ROILA, F
    TONATO, M
    DELFAVERO, A
    BALLATORI, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) : 440 - 441
  • [3] ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE - REPLY
    HRUSHESKY, WJM
    VONROEMELING, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) : 441 - 441
  • [4] LACK OF ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE
    ROEMELING, RV
    CHRISTIANSEN, NP
    HRUSHESKY, WJM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (09) : 1273 - 1276
  • [5] ORAL BIOAVAILABILITY OF HIGH-DOSE METOCLOPRAMIDE
    TAYLOR, WB
    BATEMAN, DN
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (01) : 41 - 44
  • [6] ANTIEMETIC PROPHYLAXIS WITH HIGH-DOSE METOCLOPRAMIDE OR LORAZEPAM IN VOMITING INDUCED BY CHEMOTHERAPY
    BOWCOCK, SJ
    STOCKDALE, AD
    BOLTON, JAR
    KANG, AA
    RETSAS, S
    [J]. BRITISH MEDICAL JOURNAL, 1984, 288 (6434): : 1879 - 1879
  • [7] HIGH-DOSE METOCLOPRAMIDE AND DEXAMETHASONE AS AN ANTIEMETIC IN CHEMOTHERAPY OF BREAST-CANCER
    GEZ, E
    GOODMAN, S
    ISACSON, R
    GERRA, C
    SULKES, A
    [J]. ONCOLOGY, 1986, 43 (03) : 173 - 175
  • [8] HIGH-DOSE METOCLOPRAMIDE, DEXAMETHASONE AND LORAZEPAM - AN EFFECTIVE ANTIEMETIC COMBINATION IN THE MANAGEMENT OF CYTOTOXIC INDUCED NAUSEA AND VOMITING
    PALMER, MC
    COLLS, BM
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (03): : 152 - 152
  • [9] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE
    AAPRO, MS
    PLEZIA, PM
    ALBERTS, DS
    GRAHAM, V
    JONES, SE
    SURWIT, EA
    MOON, TE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 466 - 471
  • [10] PARKINSONISM FOLLOWING IV ADMINISTRATION OF HIGH-DOSE METOCLOPRAMIDE USED AS AN ANTIEMETIC AGENT DURING CANCER-CHEMOTHERAPY
    MARKMAN, M
    NEWMAN, DR
    HAWKINS, RS
    [J]. CANCER TREATMENT REPORTS, 1985, 69 (03): : 341 - 342